Combined transcutaneous oxygen tension (tcPO(2)) and transcutaneous ca
rbon dioxide tension (tcPCO(2)) measurements were carried out at both
the subclavicular and metatarsal level in 29 controls and 100 patients
with peripheral arterial obstructive disease (PAOD) (intermittent cla
udication: n=40, critical limb ischemia: n=60). Interindividual variat
ion coefficients of arterial and subclavicular tcPCO(2) (n=94 subjects
) were superimposable, while tcPO(2) variability was twice the arteria
l value. Furthermore, arterial tensions were better predicted by tcPCO
(2) than by tcPO(2) measurement. In the 75 limbs with an ABI < 0.9 of
patients with intermittent claudication, tcPCO(2) did not differ signi
ficantly from controls (n=58 limbs), but it was elevated in those with
critical limb ischemia (n=74 limbs), although control and pathologica
l values overlapped widely even in this latter group. At variance with
tcPCO(2), tcPO(2) was lower in intermittent claudication than in cont
rols, and undetectable in most of the symptomatic limbs with critical
ischemia, irrespective of concomitant diabetes. In the overall sample
(n=255 limbs), tcPCO(2) did not show significant changes for tcPO(2) v
alues ranging from 80 to 10 mmHg, and it increased markedly in several
-but not all-patients whose tcPO(2) values were below that limit. To e
valuate further the biological significance of an increase in tissue t
cPCO(2), another sample of 24 subjects underwent acute forearm ischemi
a for a period of thirteen minutes, a maneuver that increased tcPCO(2)
markedly, indicating that this parameter is indeed a correlate of dra
stic reductions in limb perfusion. Thus, tcPCO(2) is methodologically
less variable than tcPO(2) and more predictive of arterial values. How
ever, the wide overlap with control values restrains its use as an iso
lated diagnostic tool to substantiate PAOD, even in the most advanced
stages of disease. Marked elevations in tcPCO(2) can be found in patie
nts with critical limb ischemia, although normal values may coexist wi
th low or negligible tcPO(2) levels for reasons to be clarified. Furth
er work is needed to establish the extent to which tcPCO(2) determinat
ion may complement tcPO(2) to differentiate extreme from less severe d
egrees of critical limb ischemia.